Issued Patents All Time
Showing 51–75 of 172 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11111315 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2021-09-07 |
| 11091548 | Modulation of T cells with bispecific antibodies and Fc fusions | Matthew Bernett, Seung Chu, Dilki Wickramarachichi | 2021-08-17 |
| 11084863 | Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains | Matthew Bernett, Rajat Varma, Suzanne Schubbert, Juan Diaz | 2021-08-10 |
| 11053316 | Optimized antibody variable regions | Gregory Moore, Matthew Bernett, Rumana Rashid | 2021-07-06 |
| 10982006 | Heterodimeric antibodies that bind fibroblast activation protein | Alex Nisthal, Seung Chu | 2021-04-20 |
| 10981992 | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors | Matthew Bernett, Gregory Moore, Michael Hedvat, Christine Bonzon | 2021-04-20 |
| 10968276 | Optimized anti-CD3 variable regions | Gregory Moore, Matthew Bernett, Rumana Rashid | 2021-04-06 |
| 10913803 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2021-02-09 |
| 10889653 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2021-01-12 |
| 10858417 | Heterodimeric proteins | Gregory Moore, Matthew Bernett, Rumana Rashid | 2020-12-08 |
| 10858451 | Bispecific antibodies that bind to CD38 and CD3 | Matthew Bernett, Seung Chu, Gregory Moore | 2020-12-08 |
| 10851178 | Heterodimeric human IgG1 polypeptides with isoelectric point modifications | Matthew Bernett, Gregory Moore, Rumana Rashid | 2020-12-01 |
| 10793632 | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors | Matthew Bernett, Gregory Moore, Michael Hedvat, Christine Bonzon | 2020-10-06 |
| 10787518 | Bispecific checkpoint inhibitor antibodies | Matthew Bernett, Gregory Moore, Michael Hedvat, Christine Bonzon, Alex Nisthal | 2020-09-29 |
| 10752678 | Complement component C5 antibodies | Peter C. Baciu, Yanbin Liang, Jason Guu, Matthew Bernett, Umesh Muchhal | 2020-08-25 |
| 10738133 | Heterodimeric proteins | Gregory Moore, Matthew Bernett, Rumana Rashid | 2020-08-11 |
| 10738132 | Heterodimeric proteins | Gregory Moore, Rumana Rashid, Matthew Bernett | 2020-08-11 |
| 10626182 | Optimized antibodies that target CD19 | Matthew Bernett, Seung Chu, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2020-04-21 |
| 10584176 | Fc variants with increased affinity for FcγRIIc | Gregory Alan Lazar, Wei Dang, Sher Bahadur Karki, Omid Vafa, Robert Hayes | 2020-03-10 |
| 10550185 | Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments | Matthew Bernett, Rumana Rashid, Rajat Varma, Christine Bonzon | 2020-02-04 |
| 10544187 | Targeting regulatory T cells with heterodimeric proteins | Seung Chu, Matthew Bernett, Dilki Wickramarachchi | 2020-01-28 |
| 10526417 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, Gregory Moore, Seung Chu, Rumana Rashid, Umesh Muchhal | 2020-01-07 |
| 10519242 | Targeting regulatory T cells with heterodimeric proteins | Seung Chu, Matthew Bernett, Dilki Wickramarachchi | 2019-12-31 |
| 10501543 | IL15/IL15Rα heterodimeric Fc-fusion proteins | Matthew Bernett, Rumana Rashid, Rajat Varma, Christine Bonzon | 2019-12-10 |
| 10487155 | Heterodimeric proteins | Gregory Moore, Matthew Bernett, Rumana Rashid | 2019-11-26 |